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Abstract
Background: Demographic, geographic, environmental and genetic factors influence lipids. In many countries, the
normal lipid ranges for laboratory tests are based on references from American children and adolescents. In this
work, we determined the reference intervals (RIs) for total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c),
non-high-density lipoprotein cholesterol (nHDL-c), low-density lipoprotein cholesterol (LDL-c) and triglycerides (TG) in
Brazilian healthy children and adolescents.
Methods: A cross-sectional study was conducted of 1,866 randomly sampled healthy children and adolescents from
kindergartens and schools. Blood samples were collected after a variable period of fasting based on the age of the
participant. The upper cut-off points were the 75th and 95th percentiles for TC, nHDL-c, LDL-c and TG. The 10th percentile
(low) was used as the bottom level for HDL-c. Non-parametric tests were used for statistical analyses.
Results: The following RI and 75th and 95th percentiles were observed for each age interval. The 95th percentile values
obtained for TC were: 1 to 2 years, 189 mg/dL, 3 to 8 years, 199 mg/dL; 9 to 12 years, 205 mg/dL. For the nHDL c, the
only age group 1 to 12 years, this percentile value was 150 mg/dL. For the LDL-cholesterol, the values corresponding
to the percentiles above, aged 1 to 8 years and 9 to 12 years, were 132 mg/dL 139 mg/dL, respectively. For the
triglycerides, the values corresponding to 95th percentile were: 1 year, 189 mg/dL; 2 to 5 years, 139 mg/dL; 6 to
12 years, 139 mg/dL . The 10th percentiles for HDL-c were 24 mg/dL, 28 mg/dL, 32 mg/dL and 36 mg/dL for children 1,
2, 3 and 4-12 years old, respectively.
Conclusions: The lipid reference intervals defined in the studied Brazilian children and adolescents differ from those
recommended by the international literature and should be used for clinical decisions contributing to improve the
diagnosis in this particular group in our country.
Keywords: Serum lipids, Reference intervals, Child, Adolescent
Background
Cardiovascular disease is a leading cause of death in many
countries, and epidemiological studies have linked this dis-
ease to elevations in serum lipids, such as total cholesterol
(TC), non-high-density lipoprotein cholesterol (nHDL-c),
low-density lipoprotein cholesterol (LDL-c) and triglyc-
erides (TG), and a low concentration of high-density
lipoprotein cholesterol (HDL-c); together, these changes
contribute to the development of atherosclerosis [1-6].
The onset of this disease occurs during the first years of
life, and coupled with the increased prevalence of dyslipid-
emia in the pediatric group, the evaluation of serum
concentrations of these parameters at early ages is of
utmost importance [5-9].
The definition of reference intervals (RIs) poses an ar-
duous challenge for clinical laboratories worldwide, and the
difficulties are even greater in the pediatric population
[10-12]. Ideally, laboratories should define RIs based on
their own populations [10]. This practice allows for ac-
curate clinical interpretation and decision making. How-
ever, most laboratories adopt the values reported by the
diagnostic test manufacturer or the medical literature
[13,14]. Currently, a world task force involving several cen-
ters worldwide is striving to establish pediatric RIs [15-18].
* Correspondence: adagmar.andriolo@gmail.com
†Equal contributors
3Department of Medicine, Universidade Federal de São Paulo, São Paulo,
Brazil
Full list of author information is available at the end of the article
© 2015 Slhessarenko et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Slhessarenko et al. BMC Public Health  (2015) 15:18 
DOI 10.1186/s12889-015-1359-4
The RIs for parameters such as serum lipids have been
established using national and international consensuses
that defined decision limits [10]. The decision limits spe-
cified in the medical literature are based on proposals of
the National Cholesterol Education Program (NCEP) in
1992 and were updated by the National Heart, Lung and
Blood Institute (NHLBI) in 2012 [1,5]. These guidelines
are based on studies conducted over more than 3 decades.
There are three guidelines on lipids and lipoprotein for chil-
dren and adolescents in Brazil, including the 1st Brazilian
Guideline for the Prevention of Atherosclerosis in Child-
hood and Adolescence [19], the 5th Brazilian Guideline on
Dyslipidemia and the Prevention of Atherosclerosis [20] and
the 1st Brazilian Guideline on Familial Hypercholesterolemia
[21]. However, these guidelines use the RIs, not for their
own population, but for American children and adolescents.
This fact can lead to misinterpretation because demographic
characteristics and variables, such as diet and geographic re-
gions, may interfere with these parameters [1,5,10]. There-
fore, lipid parameters for the local population determined by
local studies with well-defined protocols are essential for the
correct interpretation of laboratory tests and clinical deci-
sion making. This study determined the RIs for TC, HDL-c,
n-HDLc, LDL-c and TG in healthy children and adolescents
from Cuiabá City in Midwest Brazil.
Methods
Demographic and geographic data
The city of Cuiabá, capital of Mato Grosso, is in the cen-
tral part of South America, and it has a large, diverse
population living in three different ecosystems (Figure 1).
The ethnic composition of the city is the result of two
distinct historical phases, the first occurring during the
gold rush in the 18th century, with miscegenation between
whites and Native Indians and later with slaves from
Africa. The second phase of miscegenation occurred in
the 1970s with the migration of people from southern and
southeastern Brazil, consisting of people from many ethnic
backgrounds, mainly of European descent. The migration
was so extensive that the number of inhabitants in the
capital quintupled in three decades. Therefore, the resi-
dents of this city come from various regions, which makes
this city a representative place for an RI study from an
ethnographic point of view.
The sample size calculation was based on CLSI rec-
ommendations, which require at least 120 reference in-
dividuals per age group [10]. This cross-sectional study
evaluated 1,994 healthy children and adolescents who
were randomly sampled from 20 schools and 25 daycare
centers. Interviewers completed a written questionnaire
assessing the individual’s background, his or her relatives
and demographic and anthropometric data. The following
inclusion criteria were used for this study: children and
adolescents from 1 to 12 years, 11 months and 29 days of
age without any underlying disease or diagnosed clinical
complaints at the time of blood collection. Children and
adolescents who had a chronic disease or who were taking
medications that were not reported in the questionnaire
but were discovered during clinical evaluation were ex-
cluded. Children and adolescents were included after
parents or guardians signed the informed consent. All
data were entered into Epidata 3.1 with a double entry.
Figure 1 Map of South America: Cuiabá, Mato Grosso, is located in central Brazil; the three ecosystems of the state are shown.
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Of the 1,994 individuals who participated, 128 were ex-
cluded for the regular use of medication (n = 14, 12
children and 2 adolescents) or acute clinical symptoms
present at the time of blood collection (n = 114, 100
children and 14 adolescents). Complaints referred to at
the time of collection, which resulted in the exclusion
of children, were fever (40 children and 5 adolescents),
sore throat (28 children and adolescents 6), otalgia (27
children and 2 adolescents), dysuria (5 children) and
dengue (1 teenager). Children taking the following medi-
cations were also excluded: Carbamazepine (4 children),
Phenobarbital (3 children), Ritalin (1 child and 1 teenager),
Seretide (2 children), Sabril (1 child), prophylactic Benzetacil
(1 teenager) and tuberculosis prophylaxis (1 child).
The blood samples were collected after a fasting period
of 3 hours for children from 1 to 2 years old, 6 hours for
children from 2 to 5 years old and 12-14 hours for older
children and adolescents. The samples were processed
in a Cobas® 6000 analyzer (Roche Hitachi Cobas 6000
Analyzer, Hitachi High Technologies Corp., Tokyo, Japan)
using enzymatic colorimetric and enzymatic homogeneous
colorimetric methods. The nHDL-c and LDL-c levels were
calculated (nHDL-c = TC - HDL-c and LDL-c = TC –
HDL-c – TG/5), and the latter parameter was calculated
using the Friedwald formula.
Ethics
The study was approved by the Ethics Committees at
the Julio Müller University Hospital (# 947/2010) and the
Faculty of Medicine of the Universidade de São Paulo
(# 318/2011). The Municipal Department of Education
and Health of Cuiabá city also reviewed and approved
this study.
Statistics
We tested the homogeneity of variances using Bartlett’s
test for each parameter by age, and depending on the re-
sult, ANOVA or a Kruskal-Wallis test was used to exam-
ine differences among the age groups. The Bonferroni
post-hoc test was applied to verify pairwise differences
between the means by ages if the ANOVA or Kruskal-
Wallis test yielded a p-value less than 0.05, and age
intervals with similar means were combined. Bartlett’s
test was applied to the new age groups, followed by
ANOVA or a Kruskal-Wallis test to check whether the
new age groups maintained the age categorization. We
excluded outliers (±3 standard deviations from the
mean), and the RI was established as the resulting mean
±2 standard deviations. In addition, we calculated the
percentile distribution to establish the RIs and adopted
the criteria of the NHLBI Expert Panel on Integrated
Guidelines for Cardiovascular Health and Risk Reduction
in Children and Adolescents [5] as a proposed decision
limit for this population. For TC, nHDL-c, LDL-c and TG,
values below the 75th percentile were considered desirable
or acceptable. Values from the 75th to approximately the
95th percentile were considered borderline, and values
greater than or equal to the 95th percentile were con-
sidered high. For HDL-c, the 10th percentile was used
as the lower limit. Therefore, the participants below the
10th percentile were considered to have a low concentra-
tion. A concentration above the 50th percentile was con-
sidered desirable. The significance level was 5% for all
tests. The statistical analyses were performed using Mini-
tab software, version 15 (Minitab, PA, USA) and SPSS,
version 16 (Chicago, Illinois, USA).
Results
The final study population consisted of 1,866 healthy
children and adolescents, and 919 (49.2%) were male.
Regarding race, 64.4% were declared as mixed race, 19.6%
as white, 12.5% as black and 2.8% as Asian descendent. A
total of 97% were born in Cuiabá. Their nutritional
statuses were classified as 73.4% normal weight, 9.4%
overweight, 6.3% at risk of being overweight, 6.9% obese,
2.7% underweight and 1.2% extremely underweight.26 This
classification was performed using WHO Anthros and
WHO Anthros Plus version 3.2.2. A total of 39.2% of all
participants had a family history of diabetes, and 65.5%
and 22.4% reported a family history of hypertension and
obesity, respectively. Cardiovascular diseases, such as
myocardial infarction and stroke, were reported by 17.6%
and 12.3%, respectively. Frequency histograms of the serum
levels of TC (Figure 2), HDL-c (Figure 3), non-HDL-c
Figure 2 Histograms by age group for total cholesterol (mg/dL), after excluding outliers, with coupled Gaussian curves.
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(Figure 4), LDL-c (Figure 5) and triglycerides (Figure 6)
for all age analyzed for all groups after excluding the out-
liers are shown in Figures 2, 3, 4, 5, and 6 respectively.
The RIs for TC were calculated for 3 age groups: 1-2
years, 3-8 years and 9-12 years. Four age groups were
calculated for HDL-c: 1 year, 2 years, 3 years and 4-12
years. All children and adolescents were grouped into a
single age group for nHDL-c. Two age groups were de-
fined for LDL-c (1-8 years and 9-12 years), and 3 age
groups were used for TG (1 year, 2-5 years and 6-12
years). The proposed RIs (±2 SD) for TC were 89-196 mg/
dL for 1-2-year-olds, 102-205 mg/dL for 3-8-year-olds and
103-212 mg/dL for 9-12-year-olds. The proposed RIs
(±2 SD) for HDL-c were 18-49 mg/dL for 1-year-olds,
22-55 mg/dL for 2-year-olds, 24-61 mg/dL for 3-year-
olds and 27-69 mg/dL for 4-12-year-olds. The proposed
RI (±2 SD) for nHDL-c was 57-155 mg/dL for 1-12-
year-olds. The proposed RIs (±2 SD) for LDL-c were
43-135 mg/dL for 1-8-year-olds and 45-140 mg/dL for
9-12-year-olds. The proposed RIs (±2 SD) for TG were
26-176 mg/dL for 1-year-olds, 27-135 mg/dL for 2-5-
year-olds and 17-134 mg/dL for 6-12-year-olds. The
mean, standard deviation, maximum and minimum and
1st and 3rd quartiles values of each parameter evaluated
in their respective age groups are shown in Table 1.
Many researchers have emphasized the need to con-
sider gender in the determination of the RI for labora-
tory parameters for the pediatric population. Statistical
significance in this study was observed for some param-
eters in specific age groups, but these differences would
not likely have a relevant clinical impact (Table 2).
The following 75th and 95th percentiles were observed
for each age interval. The values obtained for TC were: 1
to 2 years, 160 mg/dL and 189 mg/dL; 3 to 8 years, 170
mg/dL and 199 mg/dL; 9 to 12 years, 176 mg/dL and
205 mg/dL, respectively. For the nHDL c, the only age
group 1 to 12 years, this percentiles values were 122 mg/dL
and 150 mg/dL, respectively. For the LDL-cholesterol, the
values corresponding to the percentiles above, aged 1 to 8
years and 9 to 12 years, were 104 mg/dL and 132 mg/dL;
106 mg/dL and 139 mg/dL, respectively. For the triglycer-
ides, the values corresponding to these percentiles
were: 1 year, 127 mg/dL and 189 mg/dL; 2 to 5 years,
98 to 139 mg/dL; 6 to 12 years, 92 mg/dL and 139 mg/dL.
The 10th percentiles for HDL-c were 24 mg/dL, 28 mg/dL,
32 mg/dL and 36 mg/dL for children 1, 2, 3 and 4-12 years
old, respectively. The clinical decision limits for each par-
ameter, calculated according to the NHLBI,5 are shown in
Tables 3 and 4.
Discussion
This study is the first performed in Brazil in a large
population that included children of early ages from the
city of Cuiabá, which is located in a central area of South
America. This city presents very interesting peculiarities
for study due to the ethnic mixture and an intense mi-
gratory movement of people from different regions of
Brazil with different eating habits and genetic backgrounds.
Cardiovascular diseases usually manifest after the fourth
decade of life, but atherosclerosis begins during an individ-
ual’s first few years [1,5,6]. This finding emphasizes the
need to determine the real concentrations of lipids in
children and adolescents and identify individuals with
cardiovascular risk indicators to enable early intervention.
The values used to diagnose dyslipidemia vary among
populations. Each country should ideally establish its own
RIs [10,22]. The reference values for lipids are probably
not country-specifics. However, it is believed that race,
lifestyle, diet, environment and economic development
Figure 3 Histograms by age group for HDL cholesterol (mg/dL), after excluding outliers, with coupled Gaussian curves.
Figure 4 Histograms by age group for nHDL cholesterol (mg/
dL), after excluding outliers, with coupled Gaussian curves.
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among different areas could account for the differences
in lipid levels in children of different countries [23].
Some studies on lipid RIs have been conducted in
Brazil, but the goals were to determine the distribution
of serum lipids in pediatric populations [24-27], except
one study in a small town in São Paulo [28,29]. This re-
port is the first Brazilian investigation to establish the RIs
for serum lipids in children and adolescents aged 1–12
years. The currently recommended lipid RIs for Brazilian
children and adolescents are based on references from
American children and adolescents, who have different
genetic profiles and distinct dietary habits. Therefore, this
study aimed to narrow this gap. The current cohort is a
specific Brazilian population, presumably with non-ideal
demographic characteristics, but the results of this study
are very interesting. The above-mentioned population has
more characteristics in common with Brazilian children
and adolescents from other regions of the country than
with any North American cohort.
The NHLBI [5] combined children and adolescents
2–19 years of age in a single group to assess their TC,
HDL-c, nHDL-c and LDL levels. Only two age groups,
0–10 years old and 10–19 years old, were used to assess
the TG levels. In the CALIPER study [30] and the present
study, however, the parameters were studied in different
age groups for each analyte.
According to the NHLBI, a TC level <170 mg/dL is de-
sirable in children and adolescents 2–19 years of age
[5]. The desirable borderline and upper limit threshold
values obtained in this study were lower in the age
group of 1–2 years. The desirable borderline and upper
concentrations for the age group of 3–8 years overlap
the recommendations of the NHLBI. Higher thresholds
were obtained in the group of 9–12 years than the thresh-
olds proposed by the American guidelines (Table 3).
The CALIPER study [30] combined children and ado-
lescents into age groups of 0–14 days, 15 days to <1 year
and 1–19 years. Our results were compared only with
this last age group. We obtained lower upper limit values
for children up to 8 years of age and values above
the CALIPER guidelines for children and adolescents
aged >9 years. Genetic differences and diverse eating
habits among the Brazilian, US and Canadian popula-
tions are possible factors for the observed differences.
Compared with the previous Brazilian study of lipids
in a single age group (2-9 years old), our values were
identical (i.e., the desirable limit for this analyte was
170 mg/dL) for 3-8 year olds [28].
Figure 5 Histograms by age group for LDL cholesterol (mg/dL), after excluding outliers, and coupled Gaussian curves.
Figure 6 Histograms by age group for triglycerides (mg/dL), after excluding outliers, with coupled Gaussian curves.
Slhessarenko et al. BMC Public Health  (2015) 15:18 Page 5 of 8
An HDL-c level >45 mg/dL is desirable, 40–45 mg/dL
is borderline, and <40 mg/dL is low according to the
NHLBI. This last value represents approximately the 10th
percentile, and it is the most relevant value in medical
practice [5]. The values corresponding to desirable, bor-
derline and lower limits in this study are below the limits
suggested by the NHLBI for the age groups of 1 year, 2
years and 3 years (Table 4). There are two potential rea-
sons for this difference: the concentration of this analyte
increases gradually over time, and this parameter was
studied in a single age group (2–19 years) in the NHLBI
study. The concentrations were higher in the age group
4–12 years, and although they were borderline and within
desirable limits, they were below the threshold compared
with the values proposed by the NHLBI (Table 4). The
CALIPER study defined the following four age groups for
HDL-c: 15 days to <1 year, 1 to <4 years, 4 to <13 years
and 13 to <19 years. The lower and upper limits obtained
in the present study were lower than the CALIPER con-
centrations in the corresponding age groups [30]. Possible
explanations include the genetic differences and diverse
eating habits of the two analyzed populations. The previ-
ous Brazilian study of lipids in children does not reference
the 10th percentile, but the desirable limit includes greater
values than the results of our study [28].
The n-HDL-c value is obtained by subtracting the
HDL-c value from the TC value. Acquiring this value
does not require fasting, which renders it very attractive,
especially among children. Moreover, this parameter is
predictive of atherosclerosis because it includes all classes
of lipoproteins [5,31]. The NHLBI considers concentra-
tions < 120 mg/dL desirable [5]. Our values are higher
than those suggested by NHLBI in the three categories,
namely, desirable, borderline and upper limit (Table 3).
The lower HDL-c concentrations in this population
(Tables 3 and 4) may explain this difference. The value
for this parameter in our study was greater than that in
Table 1 Estimated parameters for the sample distribution of children and adolescents included in the study to establish
the reference intervals for lipids after excluding the outliers
Parameter Age group (years) n Mean (SD) 1st quartile Median 3rd quartile Range (mg/dL) RI (mg/dL)
Total cholesterol (mg/dL) n = 1858 1 to 2 428 142.6 (26.7) 125 141 159.8 62 - 225 89-196
3 to 8 1,085 153.4 (25.9) 136 153 169 79 - 231 102-205
9 to 12 345 157.2 (27.3) 139 155 176 74 - 244 103-212
HDL cholesterol (mg/dL) n = 1848 1 179 33.8 (7.8) 29 34 39 12 - 56 18-49
2 245 38.8 (8.4) 33 39 44 19 - 65 22-55
3 279 42.6 (9.3) 36 42 49 22 - 71 24-61
4 to 12 1,145 48.5 (10.5) 41 48 55 20 - 82 27-69
Non-HDL cholesterol (mg/dL) n = 1854 1 to 12 1,854 106.4 (24,5) 90 104.5 122 33 - 183 57-155
LDL cholesterol (mg/dL) n = 1856 1 to 8 1,512 89.3 (23.1) 74 88 103 24 - 161 43-135
9 to 12 344 92.6 (23.5) 76.2 92 106 25 - 167 45-140
Triglycerides (mg/dL) n = 1839 1 178 100.8 (37.4) 73 93 123.8 31 - 230 26-176
2 to 5 847 81.2 (27.1) 61 77 97 25 - 175 27-135
6 to 12 814 75.7 (29.1) 54 71 90 22 - 181 17-134
SD: standard deviation; RI: reference interval.
Table 2 Statistical significance observed for the
HDL-cholesterol (HDL-c), non-HDL-cholesterol (n-HDL-c),
LDL-cholesterol (LDL-c) and triglyceride (TG) parameters
in specific age groups by gender
Parameter Age group Male Female p
value(mg/dL) (years) (mean) (mean)
HDL-c 2 40 37.7 0.026
4 – 12 49.3 47.7 0.011
n-HDL-c 1 – 12 103.9 108.7 0.001
LDL-c 1– 8 87.5 91.1 0.002
TG 2 – 5 79.1 83.2 0.027
6 – 12 70.7 80.4 0.001
Table 3 Desirable, borderline–high and high serum lipid
concentrations (mg/dL) for children and adolescents from
Cuiabá, Brazil
Parameter Age group Desirable Borderline-High High
(mg/dL) (years) <P75 P75 - P95 ≥P95
Total cholesterol 1 – 2 <160 160-188 ≥189
3 – 8 <170 170-198 ≥199
9 – 12 <176 176-204 ≥205
Non-HDL cholesterol 1 – 12 <122 122-149 ≥150
LDL cholesterol 1 – 8 <104 104-131 ≥132
9 – 12 <106 106-138 ≥139
Triglycerides 1 <127 127-188 ≥189
2 – 5 <98 98-138 ≥139
6 – 12 <92 92-138 ≥139
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the previous Brazilian lipid study [28]. The CALIPER
study did not report this parameter in their analysis [30].
A comparison between the concentrations of LDL-c
obtained in this study and the NHLBI revealed that the
LDL-c 75th percentile in our study was lower than the
NHLBI desirable limit. The LDL-c concentrations of
the borderline upper limit for the 1-8-year-old age group
overlapped with the NHLBI recommendations. The con-
centration obtained for this parameter in the age group
9–12 years was higher than the recommendations of
the NHLBI (Table 3). One possible explanation for this
discrepancy may be methodological differences because
the NHLBI data were clustered into a single age group.
Differences in the TC, HDL-c and TG values may contrib-
ute to these disparities. The value for this parameter in
our study was higher than that in the previous Brazilian
study of lipids [28]. The CALIPER study did not report
this parameter in their analysis [30].
The TG thresholds in this study were systematically
higher than those proposed by the NHLBI (Table 3) [5].
The fasting period may provide one explanation for this
effect. The recommended fasting for the collection of
this analyte is 12–14 hours, but the recommended fasting
intervals (duration between feedings) in this study were 3
hours for children up to 2 years, 6 hours for children up
to 5 years and 12-14 hours for children > 5 years.
The TG levels obtained in this study [30] show that
the upper and lower limits were systematically lower com-
pared with CALIPER. The fasting time may be one ex-
planation for this effect because fasting was not required
in the CALIPER study. The value for this parameter in
our study was greater than that in the previous Brazilian
study of lipids [28].
The weakness of this study was in not includind chil-
dren from different places around the country. However,
the studied children are descended from parents from
various regions of Brazil and have many characteristics
in common with other Brazilian children and adolescents.
In addition, not including adolescents older than 13 years
old and the long duration of fasting in younger children
are other concerns. New studies need to fully fill this gap
and include older age groups in this analysis. Further
studies of the serum lipid concentrations and clinical
and laboratory parameters already evaluated in this work
in our population will be performed in future analyses.
Conclusions
In conclusion, this study found that the distribution curves
of the lipids and lipoprotein concentrations differed
among children of different ages in Brazil, which sug-
gests the importance of considering the age partition
in developing lipid guidelines. Obtaining more discrimin-
atory data allows the identification of more sensitive
cut-offs, which are useful in guiding clinical decisions.
Moreover, the use of lipid reference ranges for children
and adolescents who have been exposed to the same demo-
graphic and geographic conditions may identify alterations
more effectively.
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